ScImage went live in March at Peak Surgery Center of Avondale, Arizona, and was developed in cooperation with the providers from multispecialty cardiovascular group Peak Heart & Vascular, which has locations in Avondale, Surprise, Ariz., and Flagstaff, Ariz. ScImage’s PICOM365 Cloud provides image review, storage and advanced structured reporting to manage the complex, measurement-centric cardiac catheterization procedures performed in the facilities.
News | Cardiovascular Information Systems (CVIS)
Outpatient Cath Lab Adopts PICOM365 Cloud With Hemodynamics 

June 29, 2021 - ScImage Inc.has partnered with National Cardiovascular Management (NCM), a national consulting and ...

Home June 29, 2021
Home
CentraCare completed the first structural heart procedure in the world guided by a new 4-D hologram technology developed by EchoPixel. The augmented reality technology aims to reduce reduce procedure time, improve accuracy of the procedure, and reduce risk of complications.
Feature | Virtual and Augmented Reality
First 4D Hologram Guided Structural Heart Procedure Performed for LAA Occlusion

June 28, 2021 — CentraCare, one of the largest health systems in Minnesota, successfully completed the first structural ...

Home June 28, 2021
Home
Circle Cardiovascular Imaging Partners With DiA Imaging Analysis to Deliver AI-Based Cardiovascular Imaging Solutions
News | Artificial Intelligence
Circle Cardiovascular Imaging Partners With DiA Imaging Analysis to Deliver AI-Based Cardiovascular Imaging Solutions

June 28, 2021 — Circle Cardiovascular Imaging Inc. and DiA Imaging Analysis Ltd. entered into a multi-year partnership ...

Home June 28, 2021
Home
Researchers analyzing surveillance data on 518 children and adolescents with MIS-C who were admitted to U.S. hospitals in 2020 fopiund those treated with intravenous immune globulin (IVIG) plus glucocorticoids had a lower risk of new or persistent cardiovascular dysfunction than IVIG alone. Left photo Getty Images, right photo Nemours Children’s Health System.
News | Coronavirus (COVID-19)
Study Provides MIS-C Treatment Guidance To Avoid Cardiovascular Dysfunction

June 28, 2021 - A recent analysis found that children and adolescents with multisystem inflammatory syndrome in children ...

Home June 28, 2021
Home
The U.S. Food and Drug Administration (FDA) announced June 25 it has added a warning on the Moderna and Pfizer COVID-19 messenger RNA (mRNA) vaccine fact sheets to explain they may cause myocarditis in rare cases as a side effect. The agency said the side effect is very rare and patients generally recover quickly, but it can disportionally affect younger patients in their teens and early 20s. Getty Images
News | Coronavirus (COVID-19) | Dave Fornell, Editor
FDA Adds Myocarditis Warning to COVID mRNA Vaccine Clinician Fact Sheets

June 28, 2021 — The U.S. Food and Drug Administration (FDA) announced June 25 it has added a warning on the Moderna and ...

Home June 28, 2021
Home
Point of care ultrasound, POCUS, combined with artificial intelligence, can help improve echo image quality by inexperienced sonographers.
News | Artificial Intelligence
Artificial Intelligence Guided Point of Care Ultrasound by Novice Users

June 25, 2021 – COVID-19 changed everything in healthcare, and a benefit from this pandemic was a surge in innovations ...

Home June 25, 2021
Home
A small number of patients develop myocarditis after receiving the messenger RNA (mRNA) COVID-19 vaccines from Pfizer and Moderna. This recently raised concerns after numbers for this adverse reaction jumped in April and May, prompting review this week by the Centers for Disease Control and Prevention (CDC) Advisory Committee on the Immunization Practices (ACIP).
Feature | Coronavirus (COVID-19) | By Dave Fornell, Editor
Overview of Myocarditis Cases Caused by the COVID-19 Vaccine

A small number of patients develop inflammation leading to myocarditis after receiving the messenger RNA (mRNA) COVID-19 ...

Home June 24, 2021
Home
Clinical trial quality data can be derived from national cardiovascular registries, which may change how trials are performed in the future.
News | Cardiovascular Clinical Studies
Study Shows ACC Registry Data Could Support Cardiac Clinical Trials

June 24, 2021 — Data captured in American College of Cardiology (ACC) National Cardiovascular Data Registry (NCDR) ...

Home June 24, 2021
Home
Surgical Site Infection (SSI) prevention remains a high priority for cardiac surgeons whose heroic efforts can be thwarted by infection. No matter how skilled a cardiac surgeon or how successful a surgery, when an SSI sets in, patients can find themselves fighting for their lives. While not unique to cardiovascular surgery, post-operative infections have severe repercussions for recovering heart surgery patients. Unfortunately, even with SSI prevention methods implemented, SSIs remain as common as 5% in car
Feature | Cardiovascular Surgery | By Noam Emanuel, Ph.D.
Rethinking Heart Surgery Surgical Site Infection Prevention

Surgical Site Infection (SSI) prevention remains a high priority for cardiac surgeons whose heroic efforts can be ...

Home June 24, 2021
Home
Small Number of Patients Have Myocarditis-like Illness After COVID-19 Vaccination. Photo by Dave Fornell
Feature | Coronavirus (COVID-19)
Small Number of Patients Have Myocarditis-like Illness After COVID-19 Vaccination

June 23, 2021 — Findings from a small study detailing the treatment of myocarditis-like symptoms in seven people after ...

Home June 23, 2021
Home
The Carmat system, an experimental artificial heart includes an autoregulation control mechanism, or Auto-Mode, that can adjust to the changing needs of patients treated for end-stage heart failure. Outcomes in the first series of patients managed with the new heart replacement pump in Auto-Mode are presented in the journal of the American Society for Artificial Internal Organs (ASAIO). 
News | Artificial Heart
Carmat Artificial Heart Shows Promising Automatic Regulation of Blood Flow

June 18, 2021 – An experimental artificial heart includes an autoregulation control mechanism, or Auto-Mode, that can ...

Home June 23, 2021
Home
The U.S. Food and Drug Administration (FDA) expanded approval for Medtronic's Arctic Front Family of cardiac cryoablation catheters for the treatment of recurrent symptomatic paroxysmal atrial fibrillation (AFib). The indication is for episodes that last less than seven continuous days and the therapy can be used as an alternative to antiarrhythmic drug (AAD) therapy as an initial rhythm control strategy. 
News | Atrial Fibrillation
FDA Expands Arctic Front Family of Cryoablation Catheters for Initial Use in Recurrent Symptomatic Paroxysmal AF

June 23, 2021 — The U.S. Food and Drug Administration (FDA) expanded approval for Medtronic's Arctic Front Family of ...

Home June 23, 2021
Home
Telecradiology remote monitroing programs grew rapidly during the COVID-19 pandemic. An example of a remote cardiac monitor that saw increased use is InfoBionic's MoMe Kardia device. It offers mobile cardiac telemetry with near real-time, on-demand full disclosure of ECG data 24/7. Using a wearable monitor, MoMe continuously records telemetry data, uploading it to a cloud-based platform that clinicians may access at anytime.
News | Remote Monitoring
Remote Patient Monitoring Represents Paradigm Shift After COVID-19

June 22, 2021 — It is no secret that the use of telehealth technologies rose dramatically with the onset of the COVID-19 ...

Home June 22, 2021
Home
The Philips Healthcare SyncVision system co-registers iFR hemodynamic blood flow measurements to live angiograms to enable easier assessment of which lesions in a vessel need to be stented and which can be left alone and treated medically.
News | FFR Technologies
First Patient Enrolled in DEFINE GPS Study to Assess PCI Guided by Co-registered iFR Versus Angiography

June 22, 2021 – Philips Healthcare announced the official start of the DEFINE GPS study, with the first patient being ...

Home June 22, 2021
Home
FDA Clears Pradaxa as First Oral Anticoagulant for Children. Dabigatran, has been cleared by the FDA
News | Antiplatelet and Anticoagulation Therapies
FDA Clears Pradaxa as First Oral Anticoagulant for Children

June 21, 2021 — The U.S. Food and Drug Administration (FDA) approved Boehringer Ingelheim's dabigatran etexilate ...

Home June 21, 2021
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now